Credit Suisse’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.17M | Hold |
31,453
| – | – | ﹤0.01% | 1792 |
|
|
2023
Q4 | $1.73M | Buy |
31,453
+5,365
| +21% | +$296K | ﹤0.01% | 1971 |
|
|
2023
Q3 | $1.51M | Buy |
26,088
+3,536
| +16% | +$205K | ﹤0.01% | 1996 |
|
|
2023
Q2 | $1.21M | Buy |
22,552
+5,115
| +29% | +$275K | ﹤0.01% | 2240 |
|
|
2023
Q1 | $693K | Buy |
17,437
+5
| +0% | +$199 | ﹤0.01% | 2527 |
|
|
2022
Q4 | $701K | Buy |
17,432
+3,411
| +24% | +$137K | ﹤0.01% | 2562 |
|
|
2022
Q3 | $450K | Buy |
14,021
+70
| +0.5% | +$2.25K | ﹤0.01% | 2827 |
|
|
2022
Q2 | $414K | Sell |
13,951
-748
| -5% | -$22.2K | ﹤0.01% | 2940 |
|
|
2022
Q1 | $413K | Sell |
14,699
-196
| -1% | -$5.51K | ﹤0.01% | 3063 |
|
|
2021
Q4 | $688K | Sell |
14,895
-12,646
| -46% | -$584K | ﹤0.01% | 2832 |
|
|
2021
Q3 | $904K | Sell |
27,541
-2,167
| -7% | -$71.1K | ﹤0.01% | 2649 |
|
|
2021
Q2 | $1.04M | Buy |
29,708
+2,798
| +10% | +$98K | ﹤0.01% | 2603 |
|
|
2021
Q1 | $972K | Sell |
26,910
-4,199
| -13% | -$152K | ﹤0.01% | 2598 |
|
|
2020
Q4 | $904K | Buy |
31,109
+3,361
| +12% | +$97.7K | ﹤0.01% | 2630 |
|
|
2020
Q3 | $782K | Sell |
27,748
-15,160
| -35% | -$427K | ﹤0.01% | 2427 |
|
|
2020
Q2 | $1.39M | Buy |
42,908
+26,390
| +160% | +$853K | ﹤0.01% | 2115 |
|
|
2020
Q1 | $672K | Buy |
16,518
+8,146
| +97% | +$331K | ﹤0.01% | 2374 |
|
|
2019
Q4 | $517K | Buy |
8,372
+1,550
| +23% | +$95.7K | ﹤0.01% | 2898 |
|
|
2019
Q3 | $497K | Buy |
6,822
+273
| +4% | +$19.9K | ﹤0.01% | 2801 |
|
|
2019
Q2 | $538K | Sell |
6,549
-701
| -10% | -$57.6K | ﹤0.01% | 2741 |
|
|
2019
Q1 | $512K | Sell |
7,250
-407
| -5% | -$28.7K | ﹤0.01% | 2751 |
|
|
2018
Q4 | $344K | Buy |
7,657
+1,591
| +26% | +$71.5K | ﹤0.01% | 2932 |
|
|
2018
Q3 | $343K | Sell |
6,066
-2,593
| -30% | -$147K | ﹤0.01% | 2993 |
|
|
2018
Q2 | $578K | Buy |
8,659
+2,028
| +31% | +$135K | ﹤0.01% | 2902 |
|
|
2018
Q1 | $385K | Sell |
6,631
-888
| -12% | -$51.6K | ﹤0.01% | 3058 |
|
|
2017
Q4 | $485K | Sell |
7,519
-4,136
| -35% | -$267K | ﹤0.01% | 2962 |
|
|
2017
Q3 | $612K | Buy |
11,655
+5,921
| +103% | +$311K | ﹤0.01% | 2954 |
|
|
2017
Q2 | $269K | Sell |
5,734
-5,936
| -51% | -$278K | ﹤0.01% | 3131 |
|
|
2017
Q1 | $578K | Sell |
11,670
-2,328
| -17% | -$115K | ﹤0.01% | 2833 |
|
|
2016
Q4 | $847K | Buy |
13,998
+1,810
| +15% | +$110K | ﹤0.01% | 2803 |
|
|
2016
Q3 | $809K | Sell |
12,188
-10,721
| -47% | -$712K | ﹤0.01% | 2804 |
|
|
2016
Q2 | $1.28M | Sell |
22,909
-380
| -2% | -$21.2K | ﹤0.01% | 2445 |
|
|
2016
Q1 | $783K | Sell |
23,289
-10,625
| -31% | -$357K | ﹤0.01% | 2631 |
|
|
2015
Q4 | $1.53M | Buy |
33,914
+21,859
| +181% | +$986K | ﹤0.01% | 2281 |
|
|
2015
Q3 | $477K | Sell |
12,055
-11,960
| -50% | -$473K | ﹤0.01% | 3228 |
|
|
2015
Q2 | $1.49M | Buy |
24,015
+9,211
| +62% | +$571K | ﹤0.01% | 2572 |
|
|
2015
Q1 | $926K | Sell |
14,804
-912
| -6% | -$57K | ﹤0.01% | 2783 |
|
|
2014
Q4 | $886K | Buy |
15,716
+1,472
| +10% | +$83K | ﹤0.01% | 2905 |
|
|
2014
Q3 | $403K | Sell |
14,244
-24,828
| -64% | -$702K | ﹤0.01% | 3398 |
|
|
2014
Q2 | $1.35M | Buy |
39,072
+18,621
| +91% | +$641K | ﹤0.01% | 2661 |
|
|
2014
Q1 | $640K | Buy |
+20,451
| New | +$640K | ﹤0.01% | 3163 |
|